Opus Genetics, Inc. (IRD) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to earnings of $0.25 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.33%. A quarter ago, it was expected that this company would post a loss of $0.29 per share when it actually produced a loss of $0.30, delivering a surprise of -3.45%.Over the last four quarters, the company has su ...